RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection: Molecular Therapy - Nucleic Acids
Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways. | Semantic Scholar
Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity | PLOS Pathogens
RIG-I activation induces Type I IFNs, which support pro-inflammatory... | Download Scientific Diagram
The RIG-I receptor adopts two different conformations for distinguishing host from viral RNA ligands - ScienceDirect
Structural Insights into RNA Recognition by RIG-I: Cell
RIG-I-like receptors: their regulation and roles in RNA sensing | Nature Reviews Immunology
RNA binding activates RIG-I by releasing an autorepressed signaling domain | Science Advances
TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination | bioRxiv
Exploiting RIG-I-like receptor pathway for cancer immunotherapy | Journal of Hematology & Oncology | Full Text
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors | Cellular & Molecular Immunology
RIG-I activation induces immunogenic modes of programmed cell death.... | Download Scientific Diagram
RIG-I-like receptor - Wikipedia
5' triphosphate hairpin RNA - RIG-I agonist | InvivoGen
Frontiers | RIG-I-Like Receptors as Novel Targets for Pan-Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral Infections
Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways. | Semantic Scholar
Impact of mRNA chemistry and manufacturing process on innate immune activation | Science Advances
Viruses | Free Full-Text | Viral Evasion of RIG-I-Like Receptor-Mediated Immunity through Dysregulation of Ubiquitination and ISGylation
Negative regulators of the RIG‐I‐like receptor signaling pathway - Quicke - 2017 - European Journal of Immunology - Wiley Online Library
Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes - ScienceDirect
RIG-I & cancer immunotherapy | Review | InvivoGen
Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists | ACS Central Science
LGP2 binds to PACT to regulate RIG-I– and MDA5-mediated antiviral responses | Science Signaling
Cancers | Free Full-Text | The Innate Immune Signalling Pathways: Turning RIG-I Sensor Activation against Cancer
Therapeutic Targeting of RIG-I and MDA5 Might Not Lead to the Same Rome: Trends in Pharmacological Sciences
